Instant NanoBiosensors Co., Ltd.

Instant NanoBiosensors (INB) is an innovation-driven biotechnology company dedicated to advancing precision diagnostics through cutting-edge proteomics and genomics solutions.

A. Light Sensing Biomarker Analyzer

The Light Sensing Biomarker Analyzer delivers high sensitivity and real-time performance for protein analysis and antibody selection. Powered by proprietary FOPPR technology, it provides label-free detection of low-abundance biomarkers using minimal sample volume while ensuring excellent reproducibility. This unique capability makes it a powerful tool for accelerating biomarker development, antibody analysis, therapeutic development, and translational research—including the early detection of blood-based biomarkers for neurodegenerative diseases such as Alzheimer's.

B. INB-G8 APOE Genotyping Analyzer

The INB-G8 Genotyping Analyzer is an automated system that integrates PCR amplification and capillary electrophoresis (CE) for comprehensive APOE six-type genotyping (ε2/ε3/ε4) in a single run. Capable of processing up to eight samples per run, the analyzer accepts buccal swab, saliva, or blood samples.

C. INVISION INLab NGS Solution

This solution is a fully automated, end-to-end next-generation sequencing (NGS) system designed to optimize precision medicine workflows and accelerate clinical decision-making for cancer treatment. The platform delivers seamless integration across the entire process, ensuring accuracy, reproducibility, and efficiency for laboratories and healthcare providers.

The solution incorporates:

✅ iNA Automated Nucleic Acid Purification Platform – featuring automated FFPE deparaffinization and high-yield cfDNA extraction (up to 8cc) for superior purity.

✅ iNA NGS Library Preparation Workstation – providing reliable, hands-free automation for complex library workflows.

✅ iNA High-Performance NGS Multiplex Panels – tailored for cancer monitoring, mutation detection, and therapy guidance.

✅ iNA One-click CAP-certified Reporting Software – integrated with LIMS to generate standardized, actionable reports.

D.Leukemia INLab NGS Solution

The Leukemia INLab NGS Solution is a next-generation sequencing platform designed for comprehensive leukemia genotyping, MRD tracking, and precision diagnostics. It combines advanced chemistry and automation to deliver rapid, accurate, and cost-efficient genomic insights.

Key Advantages:

✅ DimerOff™ Technology: Significantly reduces primer-dimer formation and sequencing noise, ensuring cleaner data and enhanced mutation detection sensitivity.

✅ Efficiency at Scale: Achieves up to 50% lower sequencing cost with a three-day turnaround time, optimizing laboratory throughput.

✅ MRD & MPN Tracking: Enables precise monitoring of measurable residual disease and myeloproliferative neoplasms, supporting personalized treatment and long-term follow-up.

✅ Custom Clinical Panels: Offers flexible, cost-effective NGS panel development for both clinical practice and translational research applications.

✅ Global Accessibility: Designed for cost-effective implementation across decentralized and international clinical settings, making high-quality genomic testing more accessible.

🚀 To expand global access to this proven model, Instant NanoBiosensors is actively seeking strategic partners to collaborate on multiple fronts:

• Worldwide distribution partnerships
• OEM/ODM manufacturing and technology transfer for reagents and automated systems
• Joint development of localized NGS panels addressing region-specific diseases
• Establishment of diagnostic laboratories and clinical application centers
• Strategic investments to co-develop precision medicine markets

🔧 Why partner with us?

• Annual production capacity exceeding 300,000 reagent kits

• Reagent quality comparable to Qiagen standards

• Streamlined automation requiring only 1–2 operators

• Proprietary DimerOFF™ technology ensuring cleaner sequencing results

• Clinically validated performance in AML, MPN, and solid tumor diagnostics